Gline Matthew

CEO Gline Matthew sells 289.8K shares at $29.16; holds 16.74M post-sale amid -76.7% annual revenue decline.

CEO Gline Matthew sold 289,774 shares of ROIV at $29.16, reducing his holdings by 1.7% to 16.74M shares. The sale occurred near the 52-week high (stock currently at $29.08, within 2.5% of the $29.83 peak), and ROIV has gained 26.5% over 90 days. However, the fundamental picture is deteriorating sharply: Roivant's annual revenue contracted 76.7% year-over-year to just $2.0M in the latest quarter, and the company posted a $-265.9M net loss over its most recent full fiscal year. At the same ticker, the CEO's prior 2 sales (December 2025) each showed positive 90-day returns of +29.4%, and his cross-ticker sell history has a 25% well-timed rate (meaning 75% of his prior sales were poorly timed, followed by further stock gains). This sale occurs against a backdrop of severe top-line contraction and deep unprofitability, creating a potential divergence between recent price momentum and operating fundamentals that warrants investor scrutiny of the company's path to profitability.

CEO Matthew Gline sold 1,740,000 shares (1.74M) for $37,723,200 at $21.68 on 2025-12-15, reducing stake by 9.1%.

CEO Matthew Gline executed 3 separate sales totaling 1,740,000 shares (1.74M shares) for $37,723,200.00, reducing his holdings from 19,027,081 shares to 17,287,081 shares at an average price of $21.68. The sale occurred near the 52-week high ($22.94), with stock trading at $22.70 currently and up 10.4% over the prior 30 days and 50.4% over 90 days. Gline's cross-ticker track record shows 100% well-timed selling performance (average 90d return after prior sells: -1.4% and -1.9%, indicating stock declined after his sales), and his prior trade at ROIV in September 2025 was similarly well-timed at the 90-day mark. However, the company's fundamentals present a stark counterpoint: latest quarterly revenue stands at $1,571,000 (declining 76.7% year-over-year), net losses reached $113,519,000 for the most recent period, and the company remains unprofitable with a $15.8B market cap that appears disconnected from revenue-generation scale. The timing of the sale near-peak prices, combined with deteriorating financial results and the CEO's established pattern of well-timed selling exits, warrants investor scrutiny of whether recent stock strength reflects durable operational recovery or near-term momentum detached from underlying metrics.

CEO Matthew Gline purchased 3,315 shares of ROIV at $15.07 on 2025-09-18 (total $49,957.05)

CEO Matthew Gline purchased 3,315 shares at $15.07 during a period of strong recent momentum (30-day change: +28.3%, 90-day change: +31.8%), with the stock near its 52-week high of $15.28. The transaction is modest in scale relative to his substantial holdings of 17.29M shares post-transaction. However, the company's fundamentals present a significant constraint: annual revenue growth is -76.7%, the latest quarter reported only $2.2M in revenue, and net income was $-223.4M over the most recent full fiscal year. His prior open-market trade at this ticker (a sell on 2024-09-23) was well-timed, with the stock declining afterward. This buy transaction occurs after a substantial recent rally, not during a period of weakness, which limits the buy's signaling strength given the deteriorating operational backdrop.

CEO Gline Matthew sold 1,983,257 shares (1.98M) of ROIV at $11.79 for $23.4M; retains 17.37M shares post-sale

Gline Matthew, as CEO, executed a substantial single-transaction sale of 1,983,257 shares representing a 10.2% reduction in his pre-transaction holdings of 19,355,261 shares. The sale occurred at $11.79 per share, generating $23,382,600.03 in proceeds, against a current market price of $11.69 and a 52-week high of $13.19. The timing coincides with ROIV trading -11.4% from its 52-week peak and follows strong 90-day performance of +10.6%, yet precedes a recent deterioration of -1.6% over 30 days. ROIV's fundamentals show exceptional profitability with net income of $95,297,000.00 against revenue of $55,132,000.00 (suggesting significant non-operating gains), a P/E of 1.83, and 103.6% annual revenue growth, though the disconnect between net income and revenue warrants scrutiny. The CEO's retention of 17,372,004 shares indicates continued material ownership stake, but the scale and single-block structure of this divestiture—executed as the stock moved away from its recent peak—establishes a significant change in his position concentration.